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Abstract
Background: Single-gene disorders related to ischemic stroke seem to be an important cause of stroke in young
patients without known risk factors. To identify new genes responsible of such diseases, we studied a
consanguineous Moroccan family with three affected individuals displaying hereditary leucoencephalopathy with
ischemic stroke, dysmorphic syndrome and retinitis pigmentosa that appears to segregate in autosomal recessive
pattern.
Methods: All family members underwent neurological and radiological examinations. A genome wide search was
conducted in this family using the ABI PRISM linkage mapping set version 2.5 from Applied Biosystems. Six
candidate genes within the region linked to the disease were screened for mutations by direct sequencing.
Results: Evidence of linkage was obtained on chromosome 17q24.2-25.3. Analysis of recombination events and
LOD score calculation suggests linkage of the responsible gene in a genetic interval of 11 Mb located between
D17S789 and D17S1806 with a maximal multipoint LOD score of 2.90. Sequencing of seven candidate genes in this
locus, ATP5H, FDXR, SLC25A19, MCT8, CYGB, KCNJ16 and GRIN2C, identified three missense mutations in the FDXR
gene which were also found in a homozygous state in three healthy controls, suggesting that these variants are
not disease-causing mutations in the family.
Conclusion: A novel locus for leucoencephalopathy with ischemic stroke, dysmorphic syndrome and retinitis
pigmentosa has been mapped to chromosome 17q24.2-25.3 in a consanguineous Moroccan family.
Background
Nuclear single-gene disorders related to ischemic stroke
are an important cause of stroke, especially in young
patients without known risk factors [1]. These diseases
could be associated with different stroke phenotypes
including arterial dissection, small vessel, and large ves-
sel which are inherited as dominant, recessive or X
linked trait. Up to date, 4 loci have been described for
the autosomal dominant form. Cerebral Autosomal-
Dominant Arteriopathy with Subcortical Infarcts and
Leukoencephalopathy (CADASIL) which is a generalized
disease of the small arteries, largely predominating in
the brain caused by mutations in NOTCH3 gene [2,3].
Hereditary endotheliopathy with retinopathy, nephropa-
thy, and stroke (HERNS) is a rare multisystemic disease
presenting with leukoencephalopathy, progressive visual
loss and nephropathy due to mutations in the TREX1
gene [4]. Marfan syndrome (MFS) which is a connective
tissue disorder with multisystemic manifestations invol-
ving skeletal, cardiovascular and ocular systems caused
by mutations in a very large gene FBN1 [5]. The Ehlers-
Danlos syndrome type IV (EDS) is a connective tissue
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cent skin, easy bruising, and severe arterial, digestive
and uterine complications resulting from mutations in
COL3A1 gene [6].
In addition to the autosomal dominant forms, three
autosomal recessive forms have been also reported. Cer-
ebral autosomal recessive arteriopathy with subcortical
infarcts and leukoencephalopathy (CARASIL) is a cere-
bral small vessel disease accompanied by alopecia and
spondylosis caused by mutations in the HTRA1 gene
[7]. Pseudoxanthoma elasticum (PXE), associated with
stenotic lesions of the distal carotid artery and with
small vessel disease, is characterized by skin, eyes, and
cardiovascular complications and related to mutations in
the ABCC6 gene on chromosome 16p13.1 [8]. The
homocystinuria is characterized by developmental delay/
intellectual disability, ectopia lentis and/or severe myo-
pia, skeletal abnormalities and thromboembolism caused
by mutations in the CBS gene [9].
Fabry disease (FD) is a progressive X-linked inherited
disorder of glycosphingolipid metabolism due to defi-
cient or absent lysosomal alpha-galactosidase A activity.
FD is associated with Cerebrovascular symptoms due to
the damage of small and large blood vessels, progressive
renal failure, cardiac disease, small-fiber peripheral neu-
ropathy, and skin lesions caused by mutation in the
GLA gene at Xq22 [10].
Finally, Moyamoya disease (MMD), characterized by
bilateral stenosis and/or occlusion of the terminal por-
tion of the internal carotid artery, could be inherited as
dominant, recessive and X-linked trait [11,12]. Several
genetic loci have been reported on chromosomes 3p, 6q
and 17q but none of the relevant genes have yet been
identified [13-16].
In the present study, we report on a consanguineous
Moroccan family with three patients displaying an auto-
somal recessive leucoencephalopathy with ischemic
stroke, dysmorphic syndrome and retinitis pigmentosa.
The genome wide search mapped this new clinical entity
to a new locus on chromosome 17q24.2-25.3 in a chro-
mosomal segment of 11 Mb.
Methods
Patients
A consanguineous family of Moroccan Origin (RBT-
D A K )w a se x a m i n e db yn e u r o l o g i s t sf r o mt h eD e p a r t -
ment of Neurology and Neurogenetics, Hôpital des Spé-
cialités, Rabat, Morocco (Figure 1). Blood samples were
taken from patients and family members and genomic
DNA was extracted from peripheral blood leukocytes
using a standard phenol/chloroform method. Brain
MRIs were obtained for the three patients (V.1, V.2, and
V.4) with a high field strength system (General Electric
Sigma Excite2 1.5 Tesla System head coil antenna). The
MRI protocol included axial T2-weighted images, sagit-
tal T1-weighted, coronal T2-weighted, fluid attenuated
inversion recovery and axial diffusion-weighted images.
The MR spectroscopy, muscle biopsy and cardiac exam
were done in index patient V.2 and MR angiography
(MRA) and standard karyotype were done in patient
V.4. All the studies were carried out after approval of
the Moroccan ethical committee of biomedical research
(CERB). Patient tutors signed the consent form and gave
permission to publish their clinical data.
Genotyping and linkage analysis
A genome-wide search was conducted using the ABI
PRISM linkage mapping set version 2.5 from Applied
Biosystems. The set consists of 400 fluorescent microsa-
tellite markers, selected from the Généthon human link-
a g em a pc o v e r i n gt h ee n t i r eh u m a ng e n o m ew i t ha
resolution of approximately 10 cM. These markers were
PCR amplified according to the manufacturer’s instruc-
tions. PCR products of each panel were then pooled,
combined in a tube with GeneScan 500LIZ size standard
and loaded in an automated capillary DNA sequencer
ABI 310. Data were collected and analysed using the
ABI GENESCAN (version 2.1) and GENOTYPER (ver-
sion 2.0) software (Applied Biosystems, Foster City, CA).
The C.E.P.H. 1347-02 DNA was used as control.
On the basis of the segregation pattern observed in
the studied family, pairwise and multipoint LOD scores
were calculated using the Allegro v1.2c2 software [17],
assuming a fully penetrant autosomal recessive trait
with a disease allele frequency of 0.00005, 0% pheno-
copy and equal recombination fraction in males and
females. Haplotypes were constructed according to the
principles of Thomson (1987). The order and distance
between markers were that of the ensembl.org genetic
map.
Sequencing of candidate genes
The 5’ and 3’ UTRs and all the coding exons, including
exon-intron boundaries, of seven candidate genes were
amplified by PCR and both strands were sequenced
using Big Dye Terminator Cycle Ready Reaction Kits
(Applied Biosystems) on an ABI 310 sequencer.
Sequence chromatograms were analyzed using SeqScape
software version 2.1 (Applied Biosystems).
Results
Clinical description
In the family we investigated here, the healthy parents
and grand-parents of the affected siblings were first cou-
sins and representing one of the four consanguinity
loops in the pedigree. Thus, the segregation of the dis-
ease was in favor of an autosomal recessive mode of
inheritance.
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Page 2 of 8Patient V.1, a 36-year-old female, was a full-term baby
girl with no history of a neonatal suffering or infection.
She had a generalised hypotonia and late acquisition of
walking and talking at age of 3 years. At the age of 20,
she presented progressive choreic movements, general-
ised myoclonus and behavioural troubles. She suffered
from headache with bilateral visual loss but with no
other signs. Neurological exam at age 36 years found
mental retardation, pyramidal syndrome, strabismus and
ocular pursuit trouble. Dysmorphic syndrome, including
an oblong face, hypertelorism, arched palate, dorsal
scoliosis, pes cavus, and equinovarus, was noted.
Ophthalmologic exam found papillary pallor and fine
vessels with retinitis pigmentosa. Brain MRI showed mul-
tiple focal white-matter hyperintensities (Figure 2A).
EMG found normal motor and sensitive conductions and
EEG found a normal background activity with no epilep-
tic abnormalities. Amino acid chromatography showed
an elevation of blood levels of glutamine, glycine, alanine
and glutamate and elevated levels of urinary glycine and
basic amino acids. Blood investigations showed normal
lactate (179 mg/l) and cortisol (3.4 mg/dl). Metanephrine,
normetanephrin, ACTH, ApoA and ApoB were also
normal.
Figure 1 Haplotype reconstruction for chromosome 17q in pedigree RBT-DAK. Microsatellite markers are ordered according to the
ensembl genetic map from centromere (top) to telomere (bottom). The hatched area represents the homozygosity region for each individual.
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Page 3 of 8Patient V.2, a 33-year-old female, was a full-term baby
girl with no history of a neonatal suffering or infection
as well. Since the age of 5, she presented late psychomo-
tor acquisitions and abnormal crawling movements of
both arms. She didn’t have any seizure or motor loss.
Neurological exam at age 33 years showed mental retar-
dation, neck dystonia, and dysmorphic syndrome with
an oblong face, hypertelorism, arched palate, macroglos-
sia and pes cavus. Cardiac exam found a heart murmur
of mitral regurgitation and a hepatojugular reflux with
hepatomegaly. Ophthalmologic exam found myopic
chorioretinal degenerative lesions, with papillary pallor
and fine vessels, and retinitis pigmentosa. Axial T2-
weighted and FLAIR images showed multiple Focal
white-matter hyperintensities (Figure 2C) and MR spec-
troscopy performed at different levels showed a small
peak of lactate (Figure 2D). ENMG was difficult to per-
form but showed no signs of neuropathy. EEG found a
normal background activity with no epileptic abnormal-
ities. ECG showed a left ventricular hypertrophy with
regular sinusal rhythm and normal echocardiography.
Morphological analysis of muscle-biopsy showed no
AB
C D
Figure 2 MRI and MR spectroscopy of RBT-DAK patients. Axial T2-weighted images of patients V.1 (A) and V.4 (B), FLAIR image of patient V.2
(C) and MR spectroscopy of patient V.2 (D) showing a small peak of lactate (see arrow).
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Page 4 of 8signs of atrophy or dystrophy. The histochemical analy-
sis (NADH, SDH and COX) were normal and no red
ragged fibers were seen. Blood analysis showed normal
level of lactate at 181 mg/l. Cortisol (4.8 μg/dl). Electro-
lytes, urea, creatinin, hepatic enzymes were also normal.
Amino acid chromatography showed elevated blood
levels of glutamine, glycine, alanine and glutamate and
elevated levels of urinary glycine and basic amino acids.
Patient V.4, a 27-year-old male, presented at the age
of 7 months a fever and dystonic movements. He had
late psychomotor development, as he walked at age of 7
years and did not talk; he also had an autistic behaviour.
At the age of 17, he had several generalised seizures.
Neurological exam at age 27 years found mental retar-
dation, generalised dystonia, and pyramidal syndrome,
along with a dysmorphic syndrome including hyperte-
lorism, arched palate and dorsal scoliosis. Brain CT scan
showed a left systemised temporoparietal hypodensity
and another right temporo-occipital hypodensity evok-
ing sequellar vascular lesions (data not shown). Axial
T2-weighted and FLAIR images at different levels
s h o w e das e q u e l l a ri s c h e m i cs t r o k eo ft h el e f tp o s t e r i o r
sylvian territory (Figure 2B). The MRA was normal and
did not show signs of Moyamoya disease. Blood investi-
gations found low level of cholesterol 1.41 g/l (normal
1.50-2.50) and normal level of cortisol (6.2 μg/dl). Meta-
nephrin (0.08 mg/24 h), normetanephrin (0.17 mg/24
h), corticotrophin (17.9 ng/l), ApoA1 (0.84 g/l) and
ApoB (0.53 g/l) were also normal. He presented several
episodes of severe hypochromic microcytic anemia
which required blood transfusion. Amino acid chroma-
tography showed an elevation of blood levels of gluta-
mine, glycine, alanine and glutamate and elevated levels
of urinary glycine and basic amino acids. Chromosomal
analysis showed a normal karyotype in the 11 observed
metaphase cells.
Mapping and sequencing of candidate genes
Since no similar clinical phenotype has been reported so
far in the literature, a genome wide search was directly
conducted in all members of family RBT-DAK. Pairwise
LOD scores were negative (< -2) for all chromosomes
except markers in chromosomes 9, 14 and 17, and sig-
nificant scores were obtained only with D9S285,
D14S258 and D17S785 markers. The two locations on
chromosomes 9 and 14 were excluded by using 15 addi-
tional microsatellites which gave negative multipoint
LOD scores (data not shown). Sixteen additional mar-
kers closely linked to D17S785 were used to analyze a
24 Mb of the 17q interval flanked by D17S787 and
D17S784. Nine consecutive markers in the D17S789-
D17S1806 interval generated positive bi-point LOD
scores at θ = 0 (Table 1). The highest scores were
obtained for D17S1807 (Z = 2.8910). A maximal
multipoint LOD score of 2.90 was obtained for the
genetic interval between D17S1862 and D17S802 (Figure
3). As the family studied is highly inbred with many
consanguinity loops, the expected linked region must be
large of several cM. Therefore, evidence of linkage takes
into account the LOD score values and the analysis of
the haplotype in the family. Haplotype analysis showed
large homozygosity regions in all patients at this 17q24-
25 location. Recombination events between D17S789
and D17S949 in individual V.7 and between D17S802
and D17S1806 in individuals V.1 and V.4 defined a new
possible locus of approximately 11-Mb between markers
D17S789 and D17S1806 (Figure 1). Note that the
healthy individual V.5 is homozygous for D17S949 and
D17S1351 but her mother IV.3 is not informative for
these two markers.
This new genetic locus contains ≈ 140 known genes
according to the genome database (Ensembl.org). The
large clinical spectrum of the disease in the family RBT-
ENC and the presence of small peak of lactate found in
MR spectroscopy, make the three genes that encode
proteins with known mitochondrial functions strong
candidate for the disease. These include ATP5H, FDXR
and SLC25A19 encoding ATP synthase subunit d, ferre-
doxin-NADP (+) reductase and solute carrier family 25
(mitochondrial thiamine pyrophosphate carrier), mem-
ber 19 respectively. Since mutations in MCT8 gene lead
to a syndrome of severe psychomotor retardation [18],
we also sequenced MCT6 encoding the monocarboxylic
acid transporter 7. We next analyzed the CYGB gene,
encoding a cytoglobin which may be involved in oxygen
storage and delivery and may acts as an endogenous
Table 1 Two point LOD score for microsatellite markers
of family RBT-DAK calculated at recombination fraction θ
=0
Markers Position (Mb) θ = 0.00
D17S787 53,282,084 - ∞
D17S944 61,436,306 - ∞
D17S584 65,119,869 - ∞
D17S789 66,628,565 - ∞
D17S949 68,465,446 1.2268
D17S1351 70,672,152 1.1828
D17S1862 71,326,581 2.4988
D17S1852 71,998,011 1.3985
D17S1807 72,360,592 2.8910
D17S1839 73,801,863 2.8469
D17S785 74,431,373 2.6879
D17S937 75,347,271 2.4608
D17S802 76,234,610 2.6879
D17S1806 77,445,675 - ∞
D17S784 77,802,191 - ∞
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Page 5 of 8neuroprotective factor in focal cerebral ischemia [19].
Since glutamate and N-methyl-D-aspartate (NMDA)
receptors have been implicated in several disorders of the
central nervous system including stroke [20] and GRIN2A
and GRIN2B genes have been recently implicated in ence-
phalopathy with mental retardation and epilepsia [21], we
sequenced the GRIN2C gene encoding the glutamate
receptor, ionotropic, N-methyl D-aspartate 2 C. We also
sequenced the KCNJ16 gene since KCNJ2 and KCNJ10
have been associated with mental retardation, dysmorphic
syndrome and a CNS phenotype [22,23]. No causative
mutations were identified in the coding sequence of all
these genes. However, in the FDXR gene, we found three
missense mutations reported as SNP in ensembl.org data
base (rs1688149 (c.275A > G/p.Asp92Gly); rs690514
which was found in 4 transcripts (c.368 G > A/Arg123Gln;
c.461 G > A/p.Arg154Gln; c.497 G > A/p.Arg166Gln;
c.236 G > A/p.Arg79Gln); and rs552432 (c.887 T > C/p.
Leu296Pro)) at homozygous state in all patients and segre-
gated with the disease in the family. Sequencing of 60
DNA individual controls showed that 20/60 presented this
haplotype with the three mutations at heterozygous state
and 3/60 at homozygous state. As the disease is considered
very rare, these variants should be polymorphism rather
than causal mutations.
Discussion
Consanguineous families with rare disease are extremely
useful in defining new loci for autosomal recessive dis-
eases. In the family investigated here, the segregation of
the disease was in favor of an autosomal recessive mode
of inheritance. In all patients, the disease starts in early
infancy by psychomotor retardation and progressive dys-
tonic and choreic movements. At age of exam, all
patients presented severe mental impairment, dys-
morphic syndrome and retinitis pigmentosa. Only
patient V.4 had epilepsia with several episodes of gener-
alized seizures. Radiological investigations showed multi-
ple ischemic lesions interesting small arteries in two
patients (V.1 and V.2) and large artery in patient V.4,
whereas MRA was normal in this patient. The clinical
presentation was therefore associated in the studied
family with leucoencephalopathy with ischemic stroke,
dysmorphic syndrome and retinitis pigmentosa. Sugges-
tive linkage of the responsible gene was found on chro-
mosome 17q24.2-25.3 in an 11 Mb genetic interval
between D17S789 and D17S1806 with a maximal multi-
point LOD score of 2.90. Two loci of Autosomal domi-
nant Moyamoya disease have been mapped to
chromosome 17q. The locus of Mineharu et al. (2008)
was distal to D17S1806 marker and thus did not overlap
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Page 6 of 8with our new locus. However, it overlaps with the locus
of Yamauchi T et al. (2000) but the clinical presentation
in the family studied here was different of the one
reported for Moyamoya disease.
Seven candidate genes in this locus, ATP5H, FDXR,
SLC25A19, MCT8, CYGB, KCNJ16 and GRIN2C were
sequenced but no causative mutation was found. The
clinical presentation is very broad in the family studied
here and suggests that the disease could be due to a
nuclear mitochondrial gene, but the lactate level was
normal in blood and MR spectroscopy showed only
small peak of lactate. However, the elevated levels of
amino acids observed in the blood and urine rather sug-
gest that the defective gene may be involved in pathways
of intermediary metabolism. In these pathways, amino
acids, when deaminated, yield a-keto acids that, directly
or via additional reactions, feed into the major metabolic
pathways (e.g., Krebs cycle). More families with the
same disease showing linkage to this locus are needed
to reduce the candidate genetic interval and thus the
number of genes to be analyzed.
Conclusions
We report here the identification of a novel locus for
autosomal recessive leucoencephalopathy with ischemic
stroke, dysmorphic syndrome and retinitis pigmentosa
on chromosome 17q24.2-25.3, in a genetic interval of 11
Mb. Gene identification is ongoing and should increase
our understanding of the causes and the physiopathol-
ogy of this ischemic stroke condition.
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